Yi-Shuian Huang

Yi-Shuian Huang

Auto-generated profile, based on publicly available information

Yi-Shuian Huang

Academia Sinica

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2013 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
Hsu-Wen CHAOHsu-Wen CHAO
Hsu-Wen CHAO
LTLi-Yun Tsai
Li-Yun Tsai
YLYi-Ling Lu
Yi-Ling Lu
PLPei-Yi Lin
Pei-Yi Lin
WHWen-Hsuan Huang
Wen-Hsuan Huang
YHYi-Shuian Huang
Yi-Shuian Huang
Long-term memory requires activity-dependent synthesis of plasticity-related proteins (PRPs) to strengthen synaptic efficacy and consequently consolidate memory. Cytoplasmic polyadenylation element binding protein (CPEB)3 is a sequence-specific RNA-binding protein that regulates translation of several PRP RNAs in neurons. To understand whether CPEB3 plays a part in learning and memory, we generated CPEB3 knock-out (KO) mice and found that the null mice exhibited enhanced hippocampus-dependent, short-term fear memory in the contextual fear conditioning test and long-term spatial memory in the Morris water maze. The basal synaptic transmission of Schaffer collateral-CA1 neurons was normal but long-term depression evoked by paired-pulse low-frequency stimulation was modestly facilitated in the juvenile KO mice. Molecular and cellular characterizations revealed several molecules in regulating plasticity of glutamatergic synapses are translationally elevated in the CPEB3 KO neurons, including the scaffolding protein PSD95 and the NMDA receptors along with the known CPEB3 target, GluA1. Together, CPEB3 functions as a negative regulator to confine the strength of glutamatergic synapses by downregulating the expression of multiple PRPs and plays a role underlying certain forms of hippocampus-dependent memories.

9 December 2011 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
PCPo‐Jen Chen
Po‐Jen Chen
YHYi‐Shuian Huang
Yi‐Shuian Huang
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

22 June 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
Hsu-Wen CHAOHsu-Wen CHAO
Hsu-Wen CHAO
YLYen-Ting Lai
Yen-Ting Lai
YLYi-Ling Lu
Yi-Ling Lu
CLChi-Long Lin
Chi-Long Lin
WMWei Mai
Wei Mai
YHYi-Shuian Huang
Yi-Shuian Huang
Cytoplasmic polyadenylation element-binding protein (CPEB)3 is a nucleocytoplasm-shuttling RNA-binding protein and predominantly resides in the cytoplasm where it represses target RNA translation. When translocated into the nucleus, CPEB3 binds to Stat5b and downregulates Stat5b-dependent transcription. In neurons, the activation of N -methyl- d -aspartate receptors (NMDARs) accumulates CPEB3 in the nucleus and redistributes CPEB3 in the nucleocytoplasmic compartments to control gene expression. Nonetheless, it is unclear which karyopherin drives the nuclear import of CPEB3 and which transport direction is most affected by NMDA stimulation to increase the nuclear pool of CPEB3. Here, we have identified that the karyopherins, IPO5 and CRM1, facilitate CPEB3 translocation by binding to RRM1 and a leucine-containing motif of CPEB3, respectively. NMDAR signaling increases RanBP1 expression and reduces the level of cytoplasmic GTP-bound Ran. These changes enhance CPEB3–IPO5 interaction, which consequently accelerates the nuclear import of CPEB3. This study uncovers a novel NMDA-regulated import pathway to facilitate the nuclear translocation of CPEB3.

17 July 2010 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SPShu-Chun Peng
Shu-Chun Peng
YLYen-Ting Lai
Yen-Ting Lai
HHHsi-Yuan Huang
Hsi-Yuan Huang
HHHsien-Da Huang
Hsien-Da Huang
YHYi-Shuian Huang
Yi-Shuian Huang
CPEB3 is a sequence-specific RNA-binding protein and represses translation of its target mRNAs in neurons. Here, we have identified a novel function of CPEB3 as to interact with Stat5b and inhibit its transcription activity in the nucleus without disrupting dimerization, DNA binding and nuclear localization of Stat5b. Moreover, CPEB3 is a nucleocytoplasm-shuttling protein with predominant residence in the cytoplasm; whereas activation of NMDA receptors accumulates CPEB3 in the nucleus. Using the knockdown approach, we have found the receptor tyrosine kinase , EGFR, is a target gene transcriptionally activated by Stat5b and downregulated by CPEB3 in neurons. The increased EGFR expression in CPEB3 knockdown neurons, when stimulated with EGF, alters the kinetics of downstream signaling. Taken together, CPEB3 has a novel function in the nucleus as to suppress Stat5b-dependent EGFR gene transcription. Consequently, EGFR signaling is negatively regulated by CPEB3 in neurons.

14 November 2018 in Developmental Neurobiology
Verified
Journal Article
Closed access
PDF file
YCYan‐Chu Chen
Yan‐Chu Chen
YCYu‐Wei Chang
Yu‐Wei Chang
YHYi‐Shuian Huang
Yi‐Shuian Huang

10 February 2023 in Science
Verified
Journal Article
Closed access
YTYuta Tsukamoto
Yuta Tsukamoto
THTakahiro Hiono
Takahiro Hiono
SYShintaro Yamada
Shintaro Yamada
KMKeita Matsuno
Keita Matsuno
AFAileen Faist
Aileen Faist
HKHiroki Kato
Hiroki Kato
Orthomyxo- and bunyaviruses steal the 5′ cap portion of host RNAs to prime their own transcription in a process called “cap snatching.” We report that RNA modification of the cap portion by host 2′-O-ribose methyltransferase 1 (MTr1) is essential for the initiation of influenza A and B virus replication, but not for other cap-snatching viruses. We identified with in silico compound screening and functional analysis a derivative of a natural product from Streptomyces , called trifluoromethyl-tubercidin (TFMT), that inhibits MTr1 through interaction at its S -adenosyl- l -methionine binding pocket to restrict influenza virus replication. Mechanistically, TFMT impairs the association of host cap RNAs with the viral polymerase basic protein 2 subunit in human lung explants and in vivo in mice. TFMT acts synergistically with approved anti-influenza drugs.